Ipilimumab - CISMeF

Preferred Label : Ipilimumab;

MeSH definition : An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.;

MeSH synonym : Anti-CTLA-4 MAb Ipilimumab; Anti CTLA 4 MAb Ipilimumab; Ipilimumab, Anti-CTLA-4 MAb;

DeCS synonym : Yervoy; MDX-CTLA-4; MDX 010;

MeSH hyponym : MDX010; MDX-010; MDX CTLA 4;

MeSH Related Number : 6T8C155666;

Wikipedia link : https://en.wikipedia.org/wiki/Ipilimumab;

Details

Origin ID

D000074324;

UMLS CUI

C1367202;

ATC code(s)
- ipilimumab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Ipilimumab [NCIt concept]
- Ipilimumab (substance) [SNOMED CT concept]
- ipilimumab [International Nonproprietary Name]
Pharmacological action(s)
- Immune Checkpoint Inhibitors [MeSH Descriptor]
Record concept(s)
- Ipilimumab [MeSH concept]
- MDX 010 [MeSH concept]
- MDX-CTLA-4 [MeSH concept]
- yervoy [MeSH concept]
See also
- CTLA-4 antigen [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ipilimumab [NCIt concept]
- Ipilimumab (substance) [SNOMED CT concept]
- Product containing ipilimumab (medicinal product) [SNOMED CT concept]
- ipilimumab [ATC Code]
- ipilimumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- ipilimumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients